Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferation

Int J Pharm. 2014 Jan 30;461(1-2):519-28. doi: 10.1016/j.ijpharm.2013.12.007. Epub 2013 Dec 16.

Abstract

The role of curcumin (diferuloylmethane), for cancer treatment has been an area of growing interest. However, due to its low absorption, the poor bioavailability of curcumin limits its clinical use. In this study, we reported an approach of encapsulation a curcumin by nanoliposome to achieve an improved bioavailability of a poorly absorbed hydrophobic compound. We demonstrated that liposomal preparations to deliver curcumin increase its bioavailability. Liposomes composed of salmon's lecithin also improved curcumin bioavailability compared to those constituted of rapeseed and soya lecithins. A real-time label-free cell analysis system based on real-time cell impedance monitoring was used to investigate the in vitro cytotoxicity of liposomal preparations.

Keywords: Cancer cells; Drug encapsulation; Lecithin; Nanoliposome.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Biological Availability
  • Brassica rapa / chemistry
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cell Proliferation / drug effects
  • Curcumin / administration & dosage*
  • Curcumin / chemistry
  • Curcumin / pharmacology
  • Female
  • Glycine max / chemistry
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Lecithins / chemistry
  • Liposomes
  • MCF-7 Cells
  • Nanoparticles*
  • Salmon

Substances

  • Antineoplastic Agents
  • Lecithins
  • Liposomes
  • Curcumin